Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2007
12/13/2007WO2007078813A3 2-AMINO-5-PIPERIDINYLIMIDAZOLONE COMPOUNDS AND USE THEREOF FOR β-SECRETASE MODULATION
12/13/2007WO2007075964A8 Thrombin receptor antagonists as prophylaxis to complications from cardiopulmonary surgery
12/13/2007WO2007070865A3 Piperazine compounds as agonists of trpv4 channel receptors
12/13/2007WO2007070779A3 A method to treat premature ejaculation in humans
12/13/2007WO2007070506A3 Diaza heterocyclic sulfonamide derivatives and their uses
12/13/2007WO2007067906A3 Peptide deformylase inhibitors
12/13/2007WO2007067619A3 Certain chemical entities, compositions, and methods for modulating trpv1
12/13/2007WO2007065032A3 Compounds and methods for inhibiting viral entry
12/13/2007WO2007064926A3 Compositions containing ansamycin
12/13/2007WO2007064797A3 Inhibitors of c-met and uses thereof
12/13/2007WO2007062112A3 Glyceryl ether compounds and their use
12/13/2007WO2007061763A3 Indole orexin receptor antagonists
12/13/2007WO2007059108A3 Substituted quinolones and methods of use
12/13/2007WO2007056164A3 Aminopyrimidines useful as kinase inhibitors
12/13/2007WO2007051133A3 Substituted thiazoles and their use
12/13/2007WO2007050599A8 Ginkgolides in the treatment and prevention of ovarian cancer
12/13/2007WO2007044796A3 Pyridazinone compounds as calcilytics
12/13/2007WO2007038250A3 1,25 - dihydroxy, 20-cyclopropyl, 26-27- deuteroalkyl vitamin d3 compounds and methods of use thereof
12/13/2007WO2007038115A3 Ppar-gamma agonists for improvement of cognitive function in apoe4 negative patients
12/13/2007WO2007027566A3 Method for removing phosphate and polymer used therefore
12/13/2007WO2007011962A3 Treatment of cancer
12/13/2007WO2007002191A3 Methods for the preparation of 9-deazapurine derivatives
12/13/2007WO2007000193A9 Isoflavone nanoparticles and use thereof
12/13/2007WO2006138475A3 Mao-b inhibitors useful for treating obesity
12/13/2007WO2006116773A3 Methods, compositions, and compounds for modulation of monoacylglycerol lipase, pain, and stress-related disorders
12/13/2007WO2006115548A3 Subunit vaccine against west nile viral infection
12/13/2007WO2006113889A3 Compositions and methods for modulating interleukin-10
12/13/2007WO2006113568A8 Controlled delivery dosage form of tramadol and gabapentin
12/13/2007WO2006113471A3 N-alkyl-azacycloalkyl nmda/nr2b antagonists
12/13/2007WO2006110298A3 8-alkyl/aryl-4-aryl-2-n- (alkylamino)-n'-substituted-n'-cyanoguanidino-8h-pyrido[2,3-d]pyrimidin-7-one compounds and use thereof
12/13/2007WO2006102533A3 Pharmaceutically active lipid-based formulation of nucleoside-lipid conjugates
12/13/2007WO2006097358A3 Analgesic combination of sodium channel blockers with opioid antagonists
12/13/2007WO2006096458A3 Treatment of hyperproliferative diseases with anthraquinones
12/13/2007WO2006089942A8 Protease inhibitor precursor synthesis
12/13/2007WO2006081396A3 Compositions and methods for delivery of agents into cells
12/13/2007WO2006079720A8 Novel heterocyclic oxime derivatives, method for preparing same and use thereof as hypoglycaemic or hypolipidemic agents
12/13/2007WO2006078575A3 Fluorinated aminoalkyl-4-oxo-3,4-dihydropyrido[3,4- d] pyrimidines as inhibitors of mitotic kinesins
12/13/2007WO2006074281A3 Inhibitors of checkpoint kinases
12/13/2007WO2006065793A3 TREATMENT OF INTERSTITIAL CYSTITIS USING (6aR,10aR)-Δ8-TETRAHYDROCANNABINOL-11-OIC ACIDS
12/13/2007WO2006044663A3 THIO-siRNA APTAMERS
12/13/2007WO2005115417A3 Polycationic antimicrobial therapeutic
12/13/2007WO2005048916A3 Tetrahydrospiro-beta-carboline-1,3 '-pyrrolidine derivatives and their use in ghsr-related disorders
12/13/2007WO2005034852A3 Protein biomaterials and biocoacervates and methods of making and using thereof
12/13/2007WO2004069195A8 Methods and compositions for treating inflammatory disorders of the airways
12/13/2007WO2003037306A3 Inhalation of vapour of therapeutical substances, like e.g. cannabis extract
12/13/2007US20070287988 Method and composition for treating osteonecrosis and/or avascular necrosis
12/13/2007US20070287931 Methods and systems for administering an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders
12/13/2007US20070287755 Orally administered compound for preventing neonatal hemorrhages, in a tardy form, caused by a K-vitamin dificiency
12/13/2007US20070287754 Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor
12/13/2007US20070287753 Intranasal Administration of Ketamine to Treat Depression
12/13/2007US20070287752 Ophthalmic Compositions Comprising A Branched, Glycerol Compound
12/13/2007US20070287751 Therapy for obesity; using a secondary amino compound
12/13/2007US20070287750 Polycationic sulfonamides and use thereof
12/13/2007US20070287749 Bromfenac ophthalmic formulations and methods of use
12/13/2007US20070287748 Intermediate in the synthesis of (S)-Pregabalin; precipitation
12/13/2007US20070287747 Process for Preparing Metal Salts of Unsaturated, Short-Chain Carboxylic Acids and Use Thereof
12/13/2007US20070287746 Use of Anti-Oxidant Compounds for Muscle Recovery
12/13/2007US20070287745 Laulimalide Analogs and Uses Thereof
12/13/2007US20070287744 N-[(4,5-diphenyl-2-thienyl)methyl]sulfonamide derivatives, preparation thereof and their therapeutic application
12/13/2007US20070287743 Adamantyl Pyrrolidin-2-One Derivatives as 11-Beta Hydroxtsteroid Dehydrogenase Inhibitors
12/13/2007US20070287742 Subsitituted Gamma Lactams As Therapeutic Agents
12/13/2007US20070287741 Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals
12/13/2007US20070287740 Compositions and methods of treating middle-of-the night insomnia
12/13/2007US20070287739 Aryl-4-ethynyl-isoxazole derivatives
12/13/2007US20070287738 Substituted Cyanopyridines as protein kinase inhibitors
12/13/2007US20070287737 Novel heteroaryl-substituted arylaminopyridine derivatives as MEK inhibitors
12/13/2007US20070287736 Diphenyl Substituted Alkanes as Flap Inhibitors
12/13/2007US20070287735 Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
12/13/2007US20070287734 Preparation and utility of substituted pyrazole compounds with cannabinoid receptor activity
12/13/2007US20070287733 Method of Treating Skin Diseases
12/13/2007US20070287732 highly potent; side effect reduction; for the treatment of diseases of the respiratory, urinary and gastrointestinal systems; 3-(2-Methoxy-5-methylphenyl)-3-phenylpropionic acid-(3-benzyl-3-azabicyclo[3.1.0]hex-6-yl-carbamoyl)methyl ester; condensation; deprotection
12/13/2007US20070287731 1-Benzyl-3-[3-(3,5-dimethyl-phenyl)-5,5-dimethyl-[1,2,4]oxadiazol-4-yl]-urea; nuclear receptor-based inducible gene expression system
12/13/2007US20070287730 useful for the treatment of HIV and AIDS
12/13/2007US20070287729 Aqueous Ophthalmic Suspension of Crystalline Rebamipide
12/13/2007US20070287728 Novel Naphthyl Substituted Azabicyclo Derivatives and Their Use as Monomine Neurotransmitter Re-Uptake Inhibitors
12/13/2007US20070287727 Anti-Nicotine Treatment
12/13/2007US20070287726 5-Substituted 1H-Pyrrolo [3,2-B] Pyridines
12/13/2007US20070287725 Isoxazole, Dihydroisoxazole, And Oxadiazole Substituted Imidazo Ring Compounds And Method
12/13/2007US20070287724 Substituted Imidazoquinolines, Imidazopyridines, and Imidazonaphthyridines
12/13/2007US20070287723 2-alkyl/aryl sulphonyl-1,2,3,4-tetrahydro-9h-pyrido (3,4-b) indole-3-carboxylic acid esters/amides useful as antithrombotic agents
12/13/2007US20070287722 Drop Preparations Comprising Dimetindene
12/13/2007US20070287721 Pyrazolopyridinyl pyridine
12/13/2007US20070287719 Salts, Prodrugs and Formulations of 1-[5-(4-Amino-7-Isopropyl-7H-Pyrrolo[2,3-D]Pyrimidine-5-Carbonyl)-2-Methoxy-Phenyl]-3-(2,4-Dichloro-Phenyl)-Urea
12/13/2007US20070287718 Methods for the Treatment of Multiple Myeloma Using Roscovitine
12/13/2007US20070287717 Thienopyrimidines useful as modulators of ion channels
12/13/2007US20070287716 Pyrimidine and Quinoline Potentiators of Metabotropic Glutamate Receptors
12/13/2007US20070287715 e.g.5-(4-tert-Butylphenyl-1-(4-(2-carboxypropan-2-yloxy)phenyl)indole-2-carboxylic acid ; inhibition of the activity of microsomal prostaglandin E synthase-1, 5-lipoxygenase-activating protein (FLAP); respiratory system disorders
12/13/2007US20070287714 Warming and Nonirritating Lubricant Compositions and Method of Comparing Irritation
12/13/2007US20070287713 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
12/13/2007US20070287712 antiviral agents for the treatment of HIV and AIDS; indole and azaindole piperazine enamine derivatives; 2-((4-(2-(4-fluoro-7-(1H-1,2,3-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoacetyl)piperazin-1-yl)(phenyl)methylene)malononitrile
12/13/2007US20070287711 Fused ring heterocycle kinase modulators
12/13/2007US20070287710 Piperidinediyl-containing sulfonamide; NPY Y5 receptor antagonist activity; antiobesity agent or anorectic agent
12/13/2007US20070287709 Novel arylamino N-heteraryls as MEK inhibitors
12/13/2007US20070287708 Substituted 3-cyanopyridines as protein kinase inhibitors
12/13/2007US20070287707 Phosphodiesterase 10 inhibitors
12/13/2007US20070287706 Certain substituted quinolones, compositions, and uses thereof
12/13/2007US20070287705 Crf Receptor Antagonists and Methods Relating Thereto
12/13/2007US20070287704 7-amino-6-chloro-2-piperazin-1-yl-4-pyrrolidin-1-yl-pteridine; central nervous system, respiratory, gastrointestinal or inflammatory diseases; joints, skin or eyes diseases; cancer; phosphodiesterase 4 inhibitors
12/13/2007US20070287703 Fused Pyrimidones Useful in the Treatment and the Prevention of Cancer
12/13/2007US20070287702 Thioridazine And Derivatives Thereof For Reversing Anti-Microbial Drug-Resistance